Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial

Fig. 2

Target Renal Angiomyolipomas of a Patient with the Tuberous Sclerosis Complex. Panel a shows the target renal angiomyolipoma volume (in milliliters) at baseline. Panel b, c and d shows the target renal angiomyolipoma volume (in milliliters) after 3, 6 and 12 months of everolimus therapy. Panel e and f shows the target renal angiomyolipoma volume (in milliliters) at 6 and 12 months after stopping everolimus

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172